NDC 67157-101-50 One 25,000 mg/50 mL (500 mg/mL) Pharmacy Bulk Package vial
NDC 67157-101-51 - Tray pack of twenty five 25,000 mg/50 mL (500 mg/mL) Pharmacy Bulk Package vials
FDA approval means that ASCOR® is proven to be safe & effective for its intended use. Additionally, McGuff Pharmaceutical’s FDA approval of ASCOR® provides the regulatory pathway for continued Ascorbic Acid injection availability of the manufactured drug; no matter what happens to the regulatory restrictions on compounding pharmacies and outsourcing facilities.
There are no contraindications to using ASCOR®.
According to the FDA, a drug should be contraindicated only in those clinical situations for which the risk from use clearly outweighs any possible therapeutic benefit. Only known hazards, and not theoretical possibilities, can be the basis for a contraindication.
According to the FDA, a drug should be contraindicated only in those clinical situations for which the risk from use clearly outweighs any possible therapeutic benefit. Only known hazards, and not theoretical possibilities, can be the basis for a contraindication.
No.
Since the FDA approval of ASCOR® (Ascorbic Acid Injection, USP), all compounded products under the name of ascorbic acid or ascorbic acid (non corn) injection are essential copies of ASCOR® and are considered illegal products.
Since the FDA approval of ASCOR® (Ascorbic Acid Injection, USP), all compounded products under the name of ascorbic acid or ascorbic acid (non corn) injection are essential copies of ASCOR® and are considered illegal products.
ASCOR® Ascorbic Acid raw material and ASCOR® finished drug product were tested using scientifically reliable and repeatable test methods to determine the presence or absence of allergens and specifically corn allergens in ASCOR®.
In all cases, the test results concluded that allergens, especially corn allergens (amino acids, proteins and polypeptides) were not detected in ASCOR® raw material or ASCOR® finished drug product.
In all cases, the test results concluded that allergens, especially corn allergens (amino acids, proteins and polypeptides) were not detected in ASCOR® raw material or ASCOR® finished drug product.
Yes.
ASCOR®, its active pharmaceutical ingredient and excipients, are certified to be from non-genetically modified organisms.
ASCOR®, its active pharmaceutical ingredient and excipients, are certified to be from non-genetically modified organisms.
Yes! McGuff Pharmaceuticals was created with the sole purpose to help patients. We feel that it is our moral obligation to progress medical advances. We have supported many trials and will continue to support trials that utilize ASCOR® to help patients. You can find these trials on ClinicalTrials.gov website.
If you would like to use ASCOR® in your clinical trial, please submit your clinical trial information here.
If you would like to use ASCOR® in your clinical trial, please submit your clinical trial information here.